Literature DB >> 10440861

Nijmegen breakage syndrome: consequences of defective DNA double strand break repair.

M Digweed1, A Reis, K Sperling.   

Abstract

The autosomal recessive genetic disorder, Nijmegen Breakage Syndrome, is characterised by an excessively high risk for the development of lymphatic tumours and an extreme sensitivity towards ionising radiation. The most likely explanation for these characteristics, a deficiency in the repair of DNA lesions, has been greatly substantiated by the recent cloning of the gene mutated in Nijmegen Breakage Syndrome patients and the analysis of its protein product, nibrin. The direct involvement of this protein in the processing of DNA double strand breaks caused by ionising radiation and those also necessary for normal DNA metabolism can be correlated with many of the cellular and clinical aspects of the disease, including the cancer predisposition of patients and their heterozygous relatives. Copyright 1999 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10440861     DOI: 10.1002/(SICI)1521-1878(199908)21:8<649::AID-BIES4>3.0.CO;2-O

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  14 in total

Review 1.  Genomic integrity and the ageing brain.

Authors:  Hei-man Chow; Karl Herrup
Journal:  Nat Rev Neurosci       Date:  2015-10-14       Impact factor: 34.870

Review 2.  DNA damage responses in neural cells: Focus on the telomere.

Authors:  P Zhang; C Dilley; M P Mattson
Journal:  Neuroscience       Date:  2007-01-04       Impact factor: 3.590

3.  Drosophila ATM and ATR checkpoint kinases control partially redundant pathways for telomere maintenance.

Authors:  Xiaolin Bi; Deepa Srikanta; Laura Fanti; Sergio Pimpinelli; RamaKrishna Badugu; Rebecca Kellum; Yikang S Rong
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

4.  DNA-binding and strand-annealing activities of human Mre11: implications for its roles in DNA double-strand break repair pathways.

Authors:  M de Jager; M L Dronkert; M Modesti; C E Beerens; R Kanaar; D C van Gent
Journal:  Nucleic Acids Res       Date:  2001-03-15       Impact factor: 16.971

5.  Phenotype-based identification of mouse chromosome instability mutants.

Authors:  Naoko Shima; Suzanne A Hartford; Ted Duffy; Lawriston A Wilson; Kerry J Schimenti; John C Schimenti
Journal:  Genetics       Date:  2003-03       Impact factor: 4.562

6.  G2-phase radiation response in lymphoblastoid cell lines from Nijmegen breakage syndrome.

Authors:  A Antoccia; A di Masi; P Maraschio; M Stumm; R Ricordy; C Tanzarella
Journal:  Cell Prolif       Date:  2002-04       Impact factor: 6.831

7.  A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer.

Authors:  Joseph Vijai; Sabine Topka; Danylo Villano; Vignesh Ravichandran; Kara N Maxwell; Ann Maria; Tinu Thomas; Pragna Gaddam; Anne Lincoln; Sarah Kazzaz; Brandon Wenz; Shai Carmi; Kasmintan A Schrader; Steven N Hart; Steve M Lipkin; Susan L Neuhausen; Michael F Walsh; Liying Zhang; Flavio Lejbkowicz; Hedy Rennert; Zsofia K Stadler; Mark Robson; Jeffrey N Weitzel; Susan Domchek; Mark J Daly; Fergus J Couch; Katherine L Nathanson; Larry Norton; Gad Rennert; Kenneth Offit
Journal:  Cancer Discov       Date:  2016-09-21       Impact factor: 39.397

8.  Requirement of the MRN complex for ATM activation by DNA damage.

Authors:  Tamar Uziel; Yaniv Lerenthal; Lilach Moyal; Yair Andegeko; Leonid Mittelman; Yosef Shiloh
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

9.  Heterogeneity of humoral immune abnormalities in children with Nijmegen breakage syndrome: an 8-year follow-up study in a single centre.

Authors:  H Gregorek; K H Chrzanowska; J Michałkiewicz; M Syczewska; K Madaliński
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

10.  Plk1 and CK2 act in concert to regulate Rad51 during DNA double strand break repair.

Authors:  Keiko Yata; Janette Lloyd; Sarah Maslen; Jean-Yves Bleuyard; Mark Skehel; Stephen J Smerdon; Fumiko Esashi
Journal:  Mol Cell       Date:  2012-02-10       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.